COPENHAGEN – Danish pharmaceutical company Novo Nordisk has successfully completed the second phase 3a trial with its diabetes drug semaglutide,…
Read More
COPENHAGEN – Danish pharmaceutical company Novo Nordisk has successfully completed the second phase 3a trial with its diabetes drug semaglutide,…
Read MoreSocial and economic status does not explain the racial gaps in the care and outcomes of kids with type 1…
Read MoreWednesday is World Diabetes Day, so it’s important to educate yourself on one of the fastest-growing health epidemics across the…
Read MoreThe drastic increases in the number of people living with diabetes and the number of new cases diagnosed each year…
Read MoreIf you have diabetes, watching what you eat is one of the most important things you can do to stay…
Read More